STAT

APRIL 6, 2024

ATLANTA — Novo Nordisk’s Wegovy improved symptoms and physical function in patients who had obesity, diabetes, and a common type of heart failure, boosting Novo’s attempt to get the popular drug approved for yet another usage beyond weight loss. The study, being presented here on Saturday at the American College of Cardiology conference and published in the New England Journal of Medicine , reports results from the second large trial Novo has conducted on Wegovy in heart fai

Diabetes 350

Diabetes 350

Express Pharma

APRIL 6, 2024

Under this new partnership, Dr Reddy’s will market the drug under a second brand name Gantra in India, expanding the reach of vericiguat to meet the needs of patients with Chronic Heart Failure with reduced ejection fraction (less than 45 per cent) Dr Reddy’s Laboratories and Bayer announced that both companies have entered into a partnership to market and distribute a second brand of Vericiguat in India.

Hospitals 93

Hospitals 93

STAT

APRIL 6, 2024

STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor here , or find the submission form at the end of any First Opinion essay. “For national security, the U.S.

229

229

PharmaState Academy

APRIL 6, 2024

CASE STUDY Effective Customer Communication - Launching a New Drug in Rural India Table of Contents Case Study Introduction: As the leader of the marketing team at ABCG Pharmaceuticals, you oversee the launch of a groundbreaking new drug designed to address a prevalent health issue in rural India. Effective communication with healthcare providers and patients in remote areas is essential to ensure the successful adoption and utilization of the new medication.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Welltopia Pharmacy

APRIL 6, 2024

Rheumatoid Arthritis (RA) is a chronic autoimmune disease characterized by inflammation, pain, and joint destruction, significantly impacting patients’ quality of

Compounding 52

Compounding 52

Drug Patent Watch

APRIL 6, 2024

Annual Drug Patent Expirations for ORACEA Oracea is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from three suppliers.

52

52

Drug Patent Watch

APRIL 6, 2024

This chart shows the drugs with the most patents in Russian Federation.

73

73

Pharmacy Times

APRIL 6, 2024

This is the fifth indication for fam-trastuzumab deruxtecan-nxki (Enhertu; Daiichi Sankyo and AstraZeneca) approved by the FDA.

26

26

Pharmacy Times

APRIL 6, 2024

Although the number of clinical trials has quadrupled, the number of FDA approvals remains stable over a 10-year period, highlighting workforce challenges in clinical research.

20

20